Form 4: Therapeutic Solutions International Director Acquires 15 Million Shares

Sentiment:

SEC Form 4 Filing


Thomas Ichim, a director of Therapeutic Solutions International, acquired 15,000,000 shares of common stock at a price of $0.0007 per share on April 18, 2024.

Summary

  • On April 18, 2024, Thomas Ichim, a director of Therapeutic Solutions International, acquired 15,000,000 shares of common stock.
  • The acquisition price was $0.0007 per share.
  • Following the transaction, Ichim's total holdings amount to 167,000,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but the small price per share tempers the enthusiasm.

Positives

  • A director's purchase of a significant number of shares can be seen as a positive signal about their confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities.

Key Dates

DateDescription
04/18/2024Date of the transaction: Thomas Ichim acquired 15,000,000 shares of common stock.
04/19/2024Date of signature on the Form 4 filing.

Keywords

Therapeutic Solutions International, TSOI, insider trading, Form 4, share acquisition, Thomas Ichim, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.